Abstract
Recent advances in neuroscience and genetics have enabled a better understanding of genetically influenced differences in ethanol (“alcohol”)-related responses and differential vulnerability to alcohol dependence at the cellular and molecular levels. Heritability studies reveal that the role of genetic factors in alcoholism is largely substance-specific, with the exception of nicotine. One focus of genetic research in alcoholism is the study of functional polymorphisms influencing alcohol metabolism, such as the aldehyde dehydrogenase type 2 Glu487Lys and alcohol dehydrogenase type 2 His47Arg polymorphisms, which affect vulnerability to alcoholism via pharmacokinetic mechanisms, and cross-population studies have begun to reveal important gene-environment interactions. The other focus is on functional genetic variants of proteins involved in the neuronal response to alcohol, including alcohol sensitivity, reward, tolerance, and withdrawal. Studies on the roles of GABAA α6-amino acid substitutions in rodents in alcohol and benzodiazepine sensitivity, and potential roles in human alcohol and benzodiazepine sensitivity are reviewed. These studies, together with recently developed knowledge on a GABAA receptor gene cluster at a quantitative trait loci for alcohol withdrawal on mouse chromosome 11, indicate that research investigation of variation at GABAA neurotransmission is a promising area in the pharmacodynamics of alcohol and in differential susceptibility to alcoholism. Genes for proteins involved in alcohol-mediated reward include genes for transporters and receptors for dopamine, serotonin, opioids, and GABA. These genes and their functional variants also represent important targets for understanding alcohol's effects in humans. Identification of genes for alcoholism vulnerability is important in the near future, not only for prevention, but also for development and targeting treatments.
Footnotes
-
Send reprint requests to: David Goldman, M.D., 12420 Parklawn Dr., Park 5 Building, room 451, MSC-8110, Rockville, MD 20892. E-mail: dgneuro{at}box-d.nih.gov
- Abbreviations used are::
- ALDH2
- aldehyde dehydrogenase type 2
- ADH1
- -2, and -3, alcohol dehydrogenase types 1, 2, and 3
- LS
- long-sleep
- SS
- short-sleep
- GABA
- gamma aminobutyric acid
- GABAA
- GABA receptor type A
- ANT
- alcohol nontolerant
- QTL
- quantitative trait loci
- 5-HT1B and -3
- serotonine receptor types 1B and 3
- DRD2 and -4
- dopamine receptor types 2 and 4
- U.S. Government
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|